Works in Diabetes, Obesity & Metabolism, 2023, Vol 25, Issue 4

Results: 28

Oral insulin: A history of ambition, failure and data torturing.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 4, p. 940, doi. 10.1111/dom.14984

By:

Heise, Tim;
Plum‐Mörschel, Leona;
Zijlstra, Eric

Publication type:

Article

CGM accuracy: Contrasting CE marking with the governmental controls of the USA (FDA) and Australia (TGA): A narrative review.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 4, p. 916, doi. 10.1111/dom.14962

By:

Pemberton, John S;
Wilmot, Emma G;
Barnard‐Kelly, Katharine;
Leelarathna, Lalantha;
Oliver, Nick;
Randell, Tabitha;
Taplin, Craig E;
Choudhary, Pratik;
Adolfsson, Peter

Publication type:

Article

Association of long‐term hyperglycaemia and insulin resistance with brain atrophy and cognitive decline: A longitudinal cohort study.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 4, p. 1091, doi. 10.1111/dom.14958

By:

Yu, Ji Hee;
Kim, Regina E. Y.;
Park, So Young;
Lee, Da Young;
Cho, Hyun Joo;
Kim, Nam Hoon;
Yoo, Hye Jin;
Seo, Ji A;
Kim, Sin Gon;
Choi, Kyung Mook;
Baik, Sei Hyun;
Shin, Chol;
Kim, Nan Hee

Publication type:

Article

Body weight loss with oral semaglutide is mediated predominantly by effects other than gastrointestinal adverse events in patients with type 2 diabetes: A post hoc analysis.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 4, p. 1130, doi. 10.1111/dom.14957

By:

Meier, Juris J.;
Bardtrum, Lars;
Cheng, Alice Y. Y.;
Malling, Brian;
Montanya, Eduard;
Wagner, Lily;
Pratley, Richard E.

Publication type:

Article

Pharmacokinetic and pharmacodynamic properties of the novel basal insulin Fc (insulin efsitora alfa), an insulin fusion protein in development for once‐weekly dosing for the treatment of patients with diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 4, p. 1080, doi. 10.1111/dom.14956

By:

Heise, Tim;
Chien, Jenny;
Beals, John M.;
Benson, Charles;
Klein, Oliver;
Moyers, Julie S.;
Haupt, Axel;
Pratt, Edward John

Publication type:

Article

Validation of a diet‐induced Macaca fascicularis model of non‐alcoholic steatohepatitis with dietary and pioglitazone interventions.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 4, p. 1068, doi. 10.1111/dom.14955

By:

Camacho, Raul C.;
Polidori, David;
Chen, Tao;
Chen, Bin;
Hsu, Helen Han;
Gao, Bin;
Marella, Mathieu;
Lubomirski, Mariusz;
Beavers, Traymon;
Cabrera, Javier;
Wong, Peggy;
Nawrocki, Andrea R.

Publication type:

Article

Effect of lixisenatide on natriuretic peptides in people with type 2 diabetes and recent acute coronary syndrome: The ELIXA trial.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 4, p. 1125, doi. 10.1111/dom.14954

By:

Gerstein, Hertzel C.;
Wolsk, Emil;
Claggett, Brian;
Diaz, Rafael;
Dickstein, Kenneth;
Hess, Sibylle;
Køber, Lars;
Maggioni, Aldo P.;
McMurray, John J. V.;
Probstfield, Jeffrey L.;
Riddle, Matthew C.;
Tardif, Jean‐Claude;
Pfeffer, Marc A.

Publication type:

Article

Early type 2 diabetes treatment intensification with glucagon‐like peptide‐1 receptor agonists in primary care: An Australian perspective on guidelines and the global evidence.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 4, p. 901, doi. 10.1111/dom.14953

By:

Rasalam, Roy;
Abdo, Sarah;
Deed, Gary;
O'Brien, Richard;
Overland, Jane

Publication type:

Article

Safety and efficacy analyses across age and body mass index subgroups in East Asian participants with type 2 diabetes in the phase 3 tirzepatide studies (SURPASS programme).

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 4, p. 1056, doi. 10.1111/dom.14952

By:

Kiyosue, Arihiro;
Dunn, Julia P.;
Cui, Xuewei;
Hickey, Ana;
Hirase, Tetsuaki;
Imaoka, Takeshi;
Heine, Robert J.

Publication type:

Article

Impact of a multicomponent healthcare intervention on glycaemic control in subjects with poorly controlled type 2 diabetes: The INTEGRA study.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 4, p. 1045, doi. 10.1111/dom.14951

By:

Molló, Àngels;
Vlacho, Bogdan;
Gratacòs, Mònica;
Mata‐Cases, Manel;
Rubinat, Esther;
Berenguera, Anna;
Real, Jordi;
Puig‐Treserra, Ramon;
Cos, Xavier;
Franch‐Nadal, Josep;
Khunti, Kamlesh;
Mauricio, Dídac

Publication type:

Article

Hepatic steatosis and advanced hepatic fibrosis are independent predictors of long‐term mortality in acute myocardial infarction.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 4, p. 1032, doi. 10.1111/dom.14950

By:

Chin, YipHan;
Lim, Jieyu;
Kong, Gwyneth;
Ng, Cheng Han;
Goh, Rachel;
Muthiah, Mark;
Mehta, Anurag;
Chong, Bryan;
Lin, Chaoxing;
Chan, Kai En;
Kong, William;
Poh, Kian Keong;
Foo, Roger;
Chai, Ping;
Yeo, Tiong‐Cheng;
Low, Adrian F.;
Lee, Chi Hang;
Tan, Huay Cheem;
Chan, Mark Yan‐Yee;
Richards, A Mark

Publication type:

Article

IMpact of flash glucose Monitoring in pEople with type 2 Diabetes Inadequately controlled with non‐insulin Antihyperglycaemic ThErapy (IMMEDIATE): A randomized controlled trial.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 4, p. 1024, doi. 10.1111/dom.14949

By:

Aronson, Ronnie;
Brown, Ruth E.;
Chu, Lisa;
Bajaj, Harpreet S.;
Khandwala, Hasnain;
Abitbol, Alexander;
Malakieh, Nadia;
Goldenberg, Ronald

Publication type:

Article

Phase I studies of the safety, tolerability, pharmacokinetics and pharmacodynamics of the dual glucagon receptor/glucagon‐like peptide‐1 receptor agonist BI 456906.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 4, p. 1011, doi. 10.1111/dom.14948

By:

Jungnik, Arvid;
Arrubla Martinez, Jorge;
Plum‐Mörschel, Leona;
Kapitza, Christoph;
Lamers, Daniela;
Thamer, Claus;
Schölch, Corinna;
Desch, Michael;
Hennige, Anita M.

Publication type:

Article

Changes in the use of glucose‐lowering drugs: A Danish nationwide study.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 4, p. 1002, doi. 10.1111/dom.14947

By:

Pottegård, Anton;
Andersen, Jacob H.;
Søndergaard, Jens;
Thomsen, Reimar W.;
Vilsbøll, Tina

Publication type:

Article

A phase 2a, randomized, double‐blind, placebo‐controlled, three‐arm, parallel‐group study to assess the efficacy, safety, tolerability and pharmacodynamics of PF‐06835919 in patients with non‐alcoholic fatty liver disease and type 2 diabetes

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 4, p. 992, doi. 10.1111/dom.14946

By:

Saxena, Aditi R.;
Lyle, Stephanie‐An;
Khavandi, Kaivan;
Qiu, Ruolun;
Whitlock, Mark;
Esler, William P.;
Kim, Albert M.

Publication type:

Article

Investigating the potential non‐authorized use of two different formulations of liraglutide in Europe: A real‐world drug utilization study.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 4, p. 985, doi. 10.1111/dom.14945

By:

Sbraccia, Paolo;
Aberle, Jens;
Olsen, Anne Helene;
Rathor, Naveen;
Major‐Pedersen, Atheline

Publication type:

Article

Semaglutide delays 4‐hour gastric emptying in women with polycystic ovary syndrome and obesity.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 4, p. 975, doi. 10.1111/dom.14944

By:

Jensterle, Mojca;
Ferjan, Simona;
Ležaič, Luka;
Sočan, Aljaž;
Goričar, Katja;
Zaletel, Katja;
Janez, Andrej

Publication type:

Article

Achievement of glycaemic targets with weight loss and without hypoglycaemia in type 2 diabetes with the once‐weekly glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1 receptor agonist tirzepatide: A post hoc analysis of the SURPASS‐1 to ‐5 studies

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 4, p. 965, doi. 10.1111/dom.14943

By:

Lingvay, Ildiko;
Cheng, Alice YY.;
Levine, Joshua A.;
Gomez‐Valderas, Elisa;
Allen, Sheryl E.;
Ranta, Kari;
Torcello‐Gómez, Amelia;
Thieu, Vivian T.

Publication type:

Article

Comparison of faster‐acting aspart with insulin aspart under conditions mimicking underestimation or missed meal boluses in type 1 diabetes using closed‐loop insulin delivery.

Published in:

2023

By:

Thabit, Hood;
Mubita, Womba;
Rubio, Jose;
Karuppan, Mini;
Schofield, Jonathan;
Willinska, Malgorzata E.;
Hovorka, Roman;
Leelarathna, Lalantha

Publication type:

Case Study

Effects of once‐weekly subcutaneous semaglutide on coronary artery disease outcomes in patients with type 2 diabetes with or at high risk for cardiovascular disease: Insights from the SUSTAIN‐6 trial.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 4, p. 1117, doi. 10.1111/dom.14941

By:

Kolkailah, Ahmed A.;
Lingvay, Ildiko;
Dobrecky‐Mery, Idit;
Aharonovich, Alona;
David, Jens‐Peter;
Holse, Cecilie;
Rasmussen, Søren;
McGuire, Darren K.

Publication type:

Article

Tirzepatide versus semaglutide for weight loss in patients with type 2 diabetes mellitus: A value for money analysis.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 4, p. 961, doi. 10.1111/dom.14940

By:

Azuri, Joseph;
Hammerman, Ariel;
Aboalhasan, Enis;
Sluckis, Ben;
Arbel, Ronen

Publication type:

Article

Pioglitazone discontinuation in patients with nonalcoholic steatohepatitis is associated with disease recurrence.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 4, p. 1112, doi. 10.1111/dom.14936

By:

Bril, Fernando;
Kalavalapalli, Srilaxmi;
Lomonaco, Romina;
Cusi, Kenneth

Publication type:

Article

Current insulin infusion set failure criteria may be too stringent for real‐life settings and may skew infusion set failure outcomes in extended‐wear infusion set studies.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 4, p. 1106, doi. 10.1111/dom.14935

By:

Kastner, Jasmin R.;
Poettler, Tina;
Kopanz, Julia;
Hochfellner, Daniel A.;
Romey, Matt;
Baumann, Petra M.;
Muchmore, Douglas;
Strasma, Paul J.;
Mader, Julia K.

Publication type:

Article

A retrospective analysis of 24‐month real‐world glucose control for children and adolescents with type 1 diabetes using the MiniMed™ 670G insulin pump.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 4, p. 1101, doi. 10.1111/dom.14934

By:

Delvecchio, Maurizio;
Galati, Alessio;
Maffeis, Claudio;
Passanisi, Stefano;
Bonfanti, Riccardo;
Franceschi, Roberto;
Tornese, Gianluca;
Calzi, Elena;
Zanfardino, Angela;
Bracciolini, Giulia Patrizia;
Piccinno, Elvira

Publication type:

Article

Sodium‐glucose cotransporter‐2 inhibitor prescribing practices.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 4, p. 1136, doi. 10.1111/dom.14931

By:

Alcorn, Chris;
Subarajan, Prathayini;
Kesari, Aditya;
Lockhart, Marie;
Cottrell, Daryl;
Jordan, Kim

Publication type:

Article

Safety and efficacy of an oral insulin (Capsulin) in patients with early‐stage type 2 diabetes: A dose‐ranging phase 2b study.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 4, p. 953, doi. 10.1111/dom.14922

By:

New, Roger R. C.;
Ramanujam, Sukumar;
Chaudhari, Varsha;
Bogus, Michal;
Travers, Glen N.;
Namjoshi, Gajanan

Publication type:

Article

Oral insulin (ORMD‐0801) in type 2 diabetes mellitus: A dose‐finding 12‐week randomized placebo‐controlled study.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 4, p. 943, doi. 10.1111/dom.14901

By:

Eldor, Roy;
Francis, Bruce H.;
Fleming, Alexander;
Neutel, Joel;
Homer, Kenneth;
Kidron, Miriam;
Rosenstock, Julio

Publication type:

Article

Diabetes, Obesity and Metabolism.

Published in:: Diabetes, Obesity & Metabolism, 2023, v. 25, n. 4, p. 899, doi. 10.1111/dom.14751
Publication type:: Article